Status:
NOT_YET_RECRUITING
Ameliorated Pap Tests and Cervical Cancer Screening Participation
Lead Sponsor:
National Taiwan University Hospital
Collaborating Sponsors:
National Taiwan University Hospital Hsin-Chu Branch
National Taiwan University
Conditions:
Cervical Cancer Screening
Cervical Cancer Screening Methods
Eligibility:
FEMALE
25+ years
Phase:
NA
Brief Summary
The Pap test plays a crucial role in the early detection of cervical cancer. A pilot single-center randomized controlled trial applied the peak-end concept and added a non-painful step at the end of P...
Detailed Description
Participants: This project expects to include women just before they undergo Pap smear screening at the NTUH Healthcare System in 2026. We include eligible women aged 25 or above who have not yet unde...
Eligibility Criteria
Inclusion
- Women aged 25 or above
Exclusion
- Ongoing menstruation
- Pregnancy
- Incapability of understanding the numeric pain scales
- Any active cancer at study entry (defined as cancer diagnosed or treated within the previous 6 months, recurrent, regionally advanced or metastatic cancer)
- Previous hysterectomy, pelvic surgery, or radiotherapy
- Active vaginal or uterus infection
- Analgesic use within 24 hours
Key Trial Info
Start Date :
January 1 2026
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2032
Estimated Enrollment :
248 Patients enrolled
Trial Details
Trial ID
NCT06968871
Start Date
January 1 2026
End Date
December 31 2032
Last Update
November 14 2025
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital Yunlin Branch
Douliu, Taiwan
2
National Taiwan University Hospital Hsin-Chu Branch
Hsinchu, Taiwan
3
National Taiwan University Hospital
Taipei, Taiwan, 100
4
National Taiwan University Cancer Center
Taipei, Taiwan